MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024

Group 1 - MannKind Corporation will report its second quarter 2024 financial results on August 7, 2024, before market opens [1] - A press release detailing the quarterly results will be issued approximately one hour prior to the webcast [1] - The webcast will begin at 9:00 a.m. Eastern Time and will be accessible via MannKind's website [1] Group 2 - MannKind focuses on developing and commercializing innovative inhaled therapeutic products for serious unmet medical needs [2] - The company aims to address diseases such as diabetes, NTM lung disease, pulmonary fibrosis, and pulmonary hypertension [2] - MannKind utilizes dry-powder formulations and inhalation devices for rapid and convenient delivery of medicines [2]